Bristol Myers Squibb
Pharmaceuticals
BMY
$ 51 0.81
$ 103 bn
$ 132 bn
Carbon footprint
Primary Climate Goal
This company has not set a company-wide target for an absolute reduction in GHG emissions yet
GHG emissions and Carbon intensity
Bristol Myers Squibb reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2020 at 278 Kt (-6 /-2.1% y-o-y). Also positively, carbon intensity dropped to 6.5 t (-4.4 /-40.4% y-o-y).
Bristol Myers Squibb's Scope 3 emissions tumbled to 12 Kt (
The company has not set a company-wide target for an absolute reduction in GHG emissions yet.
Copyright © 2024 Exerica. All rights reserved.